Anticancer Therapies – Webinars and Online Events

This webinar will highlight how the evaluation of IS formation at the single-cell level can support the discovery of new immunotherapies.

This event will feature discussions on novel immune checkpoint inhibitors, personalized cancer vaccines and CAR T-Cell therapies. We will also address the challenges of translating basic research into clinical practice and future directions.

Dr. Finlay discusses how cellular metabolism affects NK cell responses to tumors and viral infections, highlighting how metabolic engineering can improve NK cell function in challenging microenvironments.

Dr. Roddy O'Connor explores "hit & run" serial killing in CAR T cells, discussing how metabolic reprogramming influences their migration and cytolytic function, crucial for effective tumor targeting.

Dr. Jessica E. Thaxton discusses how metabolic stress in tumors affects immune cells, focusing on modulating T cells for lipid use and the role of Acetyl-CoA Carboxylase in limiting anti-tumor immunity.

Key advances will be highlighted across the field of immuno-oncology. Hear a cross-section of experts discuss their research with a focus on basic research and a broad range of established and novel immunotherapeutics.

Explore cutting-edge cell and gene therapies at our online symposium on March 20–21. Experts will discuss cancer immunotherapy, gene therapy vectors, stem cells, and precision oncology research.

Using the example of tumor-associated macrophages (TAMs), this webinar takes a closer look at immune cells in the tumor microenvironment (TME), helping us to gain a better understanding of how specific subtypes and their reprogramming may influence therapy efficiency.

Speaking at Cell & Gene Therapy 2023,Tracy Zhao from ACROBiosystems, presented their talk on products and services across cell therapy research and development.

In this webinar, we will guide you through the essential steps of the CAR T workflow while emphasizing the critical role of in-process control and quality control.